Literature DB >> 10969843

Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosome-mediated degradation of albumin during renal passage.

T M Osicka1, C A Houlihan, J G Chan, G Jerums, W D Comper.   

Abstract

Previous studies by our group have shown that albumin is metabolized in rodents during renal passage and excreted in the urine as a mixture of intact protein and albumin-derived fragments. The aim of this study was to examine whether albumin is metabolized during renal passage in nondiabetic volunteers and in type 1 diabetic patients with varying levels of albuminuria. Nine nondiabetic normoalbuminuric volunteers and 11 type 1 diabetic patients with albumin excretion rates varying from normoalbuminuria to macroalbuminuria were studied. Each subject received an intravenous injection of tritium-labeled albumin ([3H]-albumin). Urine was collected at 4 h and 24 h after injection and analyzed by size exclusion chromatography. The amount of intact and fragmented albumin was quantified, and each fraction was analyzed by radioimmunoassay (RIA) for albumin. [3H]-albumin in nondiabetic volunteers was metabolized during renal passage to small peptide fragments not detectable by conventional RIA (only 0.05-3.8% of the total urinary radioactivity was associated with intact albumin). The process responsible for albumin fragmentation was similar in diabetic patients with normoalbuminuria (intact albumin represented 0.01-4.0% of total urinary radioactivity). However, there was a reduction in the fragmentation ratio (fragmented:intact) in diabetic patients with micro- or macroalbuminuria (intact albumin represented 2.7-55.5%, P = 0.048). This change in the fragmentation ratio was directly related to the degree of albuminuria. These results have important implications for understanding the mechanisms underlying albuminuria in nondiabetic volunteers and type 1 diabetic patients. In nondiabetic volunteers, the renal processing of albumin involves a relatively rapid and comprehensive degradation of albumin to small fragments (range 1-15 kDa). The degradation process is inhibited in diabetic nephropathy in proportion to the level of albuminuria detected by RIA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969843     DOI: 10.2337/diabetes.49.9.1579

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

1.  Generation of urinary albumin fragments does not require proximal tubular uptake.

Authors:  Kathrin Weyer; Rikke Nielsen; Erik I Christensen; Henrik Birn
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

2.  Albumin handling by renal tubular epithelial cells in a microfluidic bioreactor.

Authors:  Nicholas Ferrell; Kevin B Ricci; Joseph Groszek; Joseph T Marmerstein; William H Fissell
Journal:  Biotechnol Bioeng       Date:  2011-11-10       Impact factor: 4.530

3.  Imaging lysosomal enzyme activity in live cells using self-quenched substrates.

Authors:  William H Humphries; Christine K Payne
Journal:  Anal Biochem       Date:  2012-03-03       Impact factor: 3.365

4.  Proteinuria causes dysfunctional autophagy in the proximal tubule.

Authors:  Angela C Nolin; Ryan M Mulhern; Maria V Panchenko; Anna Pisarek-Horowitz; Zhiyong Wang; Orian Shirihai; Steven C Borkan; Andrea Havasi
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

5.  Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy.

Authors:  Wei Jing Liu; Ting Ting Shen; Rui Hong Chen; Hong-Luan Wu; Yan Jin Wang; Jian Kun Deng; Qiu Hua Chen; Qingjun Pan; Chang-mei Huang Fu; Jing-li Tao; Dong Liang; Hua-feng Liu
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

Review 6.  Where does albuminuria come from in diabetic kidney disease?

Authors:  Wayne D Comper; Leileata M Russo
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

7.  Presence of immunounreactive albumin in the urine of diabetic patients.

Authors:  Aki Nakayama; Takashi Ida; Yoshiji Hatano; Kayoko Oohara; Hiroshi Yoshida; Toshiaki Baba; Hisashi Sakamoto; Kiyoko Shiba
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

8.  Determination of urinary peptides in patients with proteinuria.

Authors:  M Prakash; J K Shetty; S Dash; B K Barik; A Sarkar; R Prabhu
Journal:  Indian J Nephrol       Date:  2008-10

Review 9.  Albuminuria: what can we expect from the determination of nonimmunoreactive albumin?

Authors:  Stephan J L Bakker; Ron T Gansevoort; Dick de Zeeuw
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

Review 10.  Update on the glomerular filtration barrier.

Authors:  George Jarad; Jeffrey H Miner
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-05       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.